| DWS INVEST ESG EMERGING MARKETS TOP DIVIDEND USD FC | RVI EMERGENTES VALOR | 225,713267 | 02/11/2026 | 24,62% | 80,38% | **** |
| ROBECO BP US PREMIUM EQUITIES X USD | RVI USA VALOR | 212,740728 | 02/11/2026 | 24,62% | 59,16% | **** |
| AMUNDI FUNDS US EQUITY RESEARCH VALUE R2 USD (C) | RVI USA VALOR | 116,699358 | 02/11/2026 | 24,61% | 57,99% | ** |
| BROWN ADVISORY US SMALL CAP BLEND B USD DIS | RVI USA SMALL/MID CAP | 15,451141 | 02/11/2026 | 24,61% | 42,13% | ** |
| GAM STAR (LUX) - GALENA COMMODITIES A EUR HEDGED | RVI MATERIAS PRIMAS | 56,150000 | 02/11/2026 | 24,61% | 24,01% | * |
| GAM STAR (LUX) - GALENA COMMODITIES B EUR HEDGED | RVI MATERIAS PRIMAS | 76,040000 | 02/11/2026 | 24,61% | 33,64% | ** |
| GENERALI INVESTMENTS SICAV - CENTRAL & EASTERN EUROPEAN EQUITY EX | RVI EMERGENTES EUROPA | 473,736000 | 30/10/2026 | 24,61% | 109,26% | **** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 87,950000 | 02/11/2026 | 24,61% | 48,66% | ** |
| MAN SYSTEMATIC EMERGING MARKETS EQUITY D USD | RVI EMERGENTES | 234,240791 | 30/10/2026 | 24,61% | 92,11% | ***** |
| ROBECO BP US PREMIUM EQUITIES F EUR | RVI USA VALOR | 563,520000 | 02/11/2026 | 24,61% | 58,08% | **** |
